Park Ha Biological prices US$ 1.8 million private placement at US$ 0.18 per share
BYAH•Offering structure
The securities were sold to non-U.S. investors in an unregistered Regulation S offering.
Use of proceeds and warrant terms
Net funds are earmarked for working capital and general corporate purposes.
The warrants are exercisable immediately, have a five-year term, and carry a US$ 0.18 exercise price.
Private placement priced and closed
Park Ha Biological Technology priced a private placement of 10,000,000 Class A ordinary shares with 2,000,000 warrants at US$ 0.18 per share.
Gross proceeds totaled about US$ 1.8 million. The transaction closed Aug. 3, 2026.
